Edition:
United Kingdom

Karo Pharma AB (KARO.ST)

KARO.ST on Stockholm Stock Exchange

37.45SEK
23 Jan 2018
Change (% chg)

-0.05kr (-0.13%)
Prev Close
37.50kr
Open
37.50kr
Day's High
38.00kr
Day's Low
37.25kr
Volume
187,014
Avg. Vol
290,364
52-wk High
44.27kr
52-wk Low
22.70kr

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 137.09 0.136
Jun '17 142.46 0.187
Mar '17 139.33 0.246
FY 2016 Dec '16 96.45 1.355
Sep '16 85.16 0.059
Jun '16 81.91 -0.042
Mar '16 82.30 0.052
 
*Note: Units in Millions ofSwedish Krona
**Note: Units in Swedish Krona

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 20.39 85.70 32.91
P/E High - Last 5 Yrs. 17.52 302.09 46.01
P/E Low - Last 5 Yrs. 17.52 94.18 24.39
Beta 0.71 0.88 0.89
Price to Sales (TTM) 7.06 94.43 5.45
Price to Book (MRQ) 3.08 13.36 5.40
Price to Tangible Book (MRQ) -- 13.64 6.91
Price to Cash Flow (TTM) 19.20 72.87 23.44
% Owned Institutions -- 11.52 2.17

Dividends

  Company industry sector
Dividend Yield 0.70 0.31 1.50
Dividend Yield - 5 Year Avg 0.35 0.27 1.52
Dividend 5 Year Growth Rate -- 1.72 5.21
Payout Ratio(TTM) 0.00 16.22 43.69

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 73.93 401.22 9.10
Sales (TTM) vs TTM 1 Yr. Ago 100.57 71.05 5.46
Sales - 5 Yr. Growth Rate -- 33.10 10.29
EPS (MRQ) vs Qtr. 1 Yr. Ago 541.36 29.49 19.71
EPS (TTM) vs TTM 1 Yr. Ago 278.13 -- --
EPS - 5 Yr. Growth Rate -- 40.21 10.75
Capital Spending - 5 Yr. Growth Rate 15.70 40.33 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.77 2.18
Current Ratio (MRQ) 2.25 5.23 2.98
LT Debt to Equity (MRQ) 45.78 21.05 12.13
Total Debt to Equity (MRQ) 45.78 22.61 16.42
Interest Coverage (TTM) -9.49 -102.06 33.18

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 50.37 41.21 54.71
Gross Margin - 5 Yr. Avg. -- 52.54 52.40
EBITD Margin (TTM) 28.58 -- --
EBITD - 5 Yr. Avg -36.86 -239.51 15.28
Operating Margin (TTM) 20.58 -519.41 7.56
Operating Margin - 5 Yr. Avg. -43.06 -256.70 10.75
Pre-Tax Margin (TTM) 14.24 -494.96 8.34
Pre-Tax Margin - 5 Yr. Avg. -44.64 -256.63 11.15
Net Profit Margin (TTM) 28.74 -496.46 4.66
Net Profit Margin - 5 Yr. Avg. -30.81 -259.85 7.45
Effective Tax Rate (TTM) -101.89 23.29 23.07
Effective Tax Rate - 5 Yr. Avg. -- 18.77 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) 6,716,145 23,318,311 858,000,222
Net Income/Employee (TTM) 1,930,536 3,079,098 100,930,107
Receivable Turnover (TTM) -- 20.24 5.77
Inventory Turnover (TTM) -- 2.31 3.35
Asset Turnover (TTM) 0.37 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 10.69 0.09 11.00
Return on Assets - 5 Yr. Avg. -9.05 0.51 12.38
Return on Investment (TTM) 11.70 3.19 14.44
Return on Investment - 5 Yr. Avg. -13.05 3.64 16.19
Return on Equity (TTM) 15.82 4.52 16.13
Return on Equity - 5 Yr. Avg. -18.16 8.98 17.53
  1 Year 3 Year 5 Year
Sales % 402.58 94.73 --
EPS (TTM) % 192.15 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Karo Pharma AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 3.65 -- 99 48
13 Week -2.93 -- 94 61
26 Week 19.15 -- 99 71
52 Week 13.66 -- 99 47
YTD 51.68 -- 99 51
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 3.87%
# of Holders: 11
Total Shares Held: 4,242,393
3 Mo. Net Change: 1,221,674
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 8
# Reduced Positions: 0
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.